Millennium Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
JT
PA
BBA
OAG
Millennium Management's PRAX Position: Q2 2026 in Review
Millennium Management reduced its Praxis Precision Medicines (PRAX) stake by 74% in Q2 2026, selling an estimated $898K and leaving 995 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #5055.
Millennium Management first reported a position in PRAX in Q1 2021 and has held it in 19 quarters since. The position peaked at $11.6M in Q4 2024. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Millennium Management held 995 shares of Praxis Precision Medicines worth $333K as of Q2 2026.
- Millennium Management sold 2,836 Praxis Precision Medicines shares in Q2 2026, an estimated $898K.
- Praxis Precision Medicines made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #5055 holding.
- Millennium Management first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 19 quarters since.
- Millennium Management's Praxis Precision Medicines position peaked at $11.6M in Q4 2024.
- 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.